Overexpression of SIRT1 and SIRT2 promoted the survival of chronic lymphocytic leukemia (CLL) B cells and correlated with poor outcome in patients with CLL (80, 81). This evidence concerns the gene SIRT2 and B-cell chronic lymphocytic leukemia.